Bio2 Technologies received 510(k) clearance from the U.S. Food and Drug Administration for its CLM Bioactive Scaffold.
The first surgery using the Episurf Medical Knee Trochlea, designed to treat cartilage defects in the area behind the patella, was performed by Professor Peter Verdonk at AZ Monica Hospital in Belgium.
K2M announced that the first surgical case using its CAPRI Corpectomy Cage System has been successfully completed.
Medtronic executives will receive $63 million in payments when the company completes its Covidien acquisition to cover the tax inversion strategy.
Osiris Therapeutics entered into an exclusive, worldwide partnership with Stryker for the commercialization and development of its viable bone matrix tissue form.
More articles on devices:
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
